Recent studies suggest that defective ω-oxidation of ocular fatty acids/lipids secondary to mutations in CYP4V2 may contribute to the abnormal lipid metabolism in BCD patients [17], [18], [19], [20]. Here, CYP4V2 is linked to Bietti crystalline dystrophy.